Sandler Laura Lee

Insider profile

Performance

Overall performance

Performance over holding periods
30 days 90 days 120 days
Average return -59% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Sandler Laura Lee's trades of Oruka Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-01 2026-05-01 PlS Planned sale
43,472 -16.8%
238.92
US$286,222
43,472 -16.8% 238.92 US$286,222
2026-05-01 2026-05-01 PlS Planned sale
13,125 -25.1%
53.44
US$3,777,531
13,125 -25.1% 53.44 US$3,777,531
2026-05-01 2026-05-01 PlS Planned sale
32,853 -41.9%
197.51
US$1,283,013
32,853 -41.9% 197.51 US$1,283,013
2026-05-01 2026-05-01 PlS Planned sale
300 -0.1%
65.10
US$19,530
300 -0.1% 65.10 US$19,530
2026-05-01 2026-05-01 PlS Planned sale
1,800 -0.8%
64.15
US$115,468
1,800 -0.8% 64.15 US$115,468
2026-05-01 2026-05-01 PlS Planned sale
2,200 -0.9%
62.58
US$137,685
2,200 -0.9% 62.58 US$137,685
2026-05-01 2026-05-01 PrS Proposed sale
10,000
68.41
US$684,100
10,000 68.41 US$684,100
2026-03-17 2026-03-16 S Sale
600 -0.3%
41.30
US$24,780
600 -0.3% 41.30 US$24,780
2026-03-02 2026-03-02 PlS Planned sale
2,675 -1.1%
33.81
US$90,436
2,675 -1.1% 33.81 US$90,436
2026-03-02 2026-03-02 PlS Planned sale
2,325 -1.0%
33.28
US$77,386
2,325 -1.0% 33.28 US$77,386
2026-01-02 2026-01-02 PrS Proposed sale
18,000
30.31
US$545,580
18,000 30.31 US$545,580
2026-01-02 2026-01-02 PlS Planned sale
1,108 -0.5%
29.75
US$32,967
1,108 -0.5% 29.75 US$32,967
2026-01-02 2026-01-02 PlS Planned sale
3,144 -1.5%
29.08
US$91,432
3,144 -1.5% 29.08 US$91,432
2026-01-02 2026-01-02 PlS Planned sale
8,748 -4.0%
28.17
US$246,396
8,748 -4.0% 28.17 US$246,396